Chargement en cours...
BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death
Proteasome inhibitors, such as bortezomib and carfilzomib, are FDA approved for the treatment of hemopoietic cancers, but recent studies have shown their great potential for treatment of solid tumors. BaxΔ2, a unique proapoptotic Bax isoform, promotes non-mitochondrial cell death and sensitizes canc...
Enregistré dans:
| Publié dans: | Biochem Biophys Res Commun |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6022363/ https://ncbi.nlm.nih.gov/pubmed/29291406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2017.12.156 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|